Improved time-in-range on continuous glucose monitor with Technosphere insulin compared to insulin Aspart in adults with type 1 diabetes: Stat study per protocol analysis

被引：0
|
作者：
Snell-Bergeon, J. [1 ]
Akturk, H. K. [1 ]
Beck, E. A. [1 ]
Klaff, L. J. [2 ]
Bode, B. W. [3 ]
Peters, A. [4 ]
Bailey, T. S. [5 ]
Garg, S. K. [1 ]
机构：
[1] Univ Colorado, AMC, Barbara Davis Ctr Diabet, Aurora, CO USA
[2] Rainier Clin Res Ctr, Renton, WA USA
[3] Atlanta Diabet Associates, Atlanta, GA USA
[4] USC, Westside Ctr Diabet, Beverly Hills, CA USA
[5] AMCR Clin, Escondido, CA USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
677
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [41] Continuous glucose monitoring in pregnancies with type 1 diabetes: small increases in time-in-range improve maternal and perinatal outcomes
    Sobhani, Nasim C.
    Goemans, Sophie
    Nguyen, Antoinette
    Chambers, Melissa E.
    Richley, Michael
    Gabby, Lauryn C.
    Field, Nancy
    Han, Christina S.
    Ramos, Gladys A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 234 (04) : 467e1 - 467e8
  • [42] Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial
    Shah, Viral N.
    Al-Karadsheh, Amer
    Barnes, Cathy
    Mandry, Jose
    Nakhle, Samer
    Wernicke-Panten, Karin
    Kramer, Daniel
    Schmider, Wolfgang
    Pierre, Suzanne
    Teichert, Lenore
    Rotthaeuser, Baerbel
    Mukherjee, Bhaswati
    Bailey, Timothy S.
    DIABETES OBESITY & METABOLISM, 2024, 26 (02): : 540 - 547
  • [43] Improved Time-in-Range and Glycemic Variability in Adults with Type 1 Diabetes: An Analysis of 12-Week Flash Glucose Monitoring Data from a Multicenter Prospective Trial
    Guo, Lixin
    Zhang, Mei
    Kuang, Hongyu
    Li, Yuxiu
    Xiao, Xinhua
    Jia, Xiaofan
    Yang, Tao
    DIABETES, 2020, 69
  • [44] Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study
    Ozer, Kerem
    Cooper, Alison M.
    Ahn, Lily P.
    Waggonner, Cassidy R.
    Blevins, Thomas C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (04) : 286 - 292
  • [45] Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETES, 2005, 54 : A119 - A119
  • [46] Time-in-Range With Insulin Versus Metformin in Gestational Diabetes Mellitus Using Continuous Glucose Monitoring: A Randomized Control Study at a Tertiary Care Centre in South India
    Pandey, Abhishek
    Naik, Balaji Tejerao
    Uday, Rajini
    Channabasappa, Shivaprasad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [47] Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
    Ashwell, S. G.
    Gebbie, J.
    Home, P. D.
    DIABETIC MEDICINE, 2006, 23 (08) : 879 - 886
  • [48] Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial
    Shaoyong Xu
    Xiangyang Liu
    Jie Ming
    Qiuhe Ji
    Trials, 17
  • [49] Clinical efficacy and safety of insulin aspart compared with regular human insulin in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis
    Wojciechowski, Piotr
    Niemczyk-Szechowska, Patrycja
    Olewinska, Elzbieta
    Jaros, Patrycja
    Mierzejewska, Barbara
    Skarzynska-Duk, Joanna
    Malecki, Maciej T.
    Rys, Przemyslaw
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (03): : 141 - 151
  • [50] Risk for Nocturnal Hypoglycemia With Biphasic Insulin Aspart 30 Compared With Biphasic Human Insulin 30 in Adults With Type 2 Diabetes Mellitus: A Meta-Analysis
    Davidson, Jaime A.
    Liebl, Andreas
    Christiansen, Jens S.
    Fulcher, Greg
    Ligthelm, Robert J.
    Brown, Paul
    Gylvin, Titus
    Kawamori, Ryuzo
    CLINICAL THERAPEUTICS, 2009, 31 (08) : 1641 - 1651
12345